Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations
Haematologica. 2025 Jan 2.
doi: 10.3324/haematol.2024.285466.
Online ahead of print.
1 The Epi-/Genome lab, Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen.
2 The Epi-/Genome lab, Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen.
3 Department of Hematology, Odense University Hospital, Odense.
4 Department of Hematology, Zealand University Hospital, Roskilde.
5 Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; The Finsen Laboratory, Faculty of Health Sciences, Copenhagen University Hospital - Rigshospitalet, Copenhagen.
6 Department of Epigenetics, Van Andel Institute, Michigan.
7 Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark; The Finsen Laboratory, Faculty of Health Sciences, Copenhagen University Hospital - Rigshospitalet, Copenhagen.
8 The Epi-/Genome lab, Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark; Department of Biomedical Sciences, University of Copenhagen, Copenhagen.
9 The Epi-/Genome lab, Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Biotech Research and Innovation Center (BRIC), University of Copenhagen, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen. [email protected].